GlaxoSmithkline Consumer Healthcare Ltd(Merged) Financials
GlaxoSmithkline Consumer Healthcare Ltd(Merged) Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2019 | Sep 2019 | Jun 2019 |
|---|---|---|---|
| Revenue | 1,274.90 | 1,423.22 | 1,320.90 |
| Operating Expense | 886.78 | 949.28 | 913.92 |
| Net Profit | 276.63 | 345.31 | 248.08 |
| Net Profit Margin | 21.70 | 24.26 | 18.78 |
| Earning Per Share | 65.77 | 82.10 | 58.98 |
| EBIDTA | 386.61 | 441.64 | 405.16 |
| Effective Tax Rate | 23.01 | 15.66 | 33.36 |
| Particulars | Dec 2019 |
|---|---|
| Revenue | 1274.90 |
| Operating Expense | 886.78 |
| Net Profit | 276.63 |
| Net Profit Margin | 21.70 |
| Earning Per Share | 65.77 |
| EBIDTA | 386.61 |
| Effective Tax Rate | 23.01 |
Invest in GlaxoSmithkline Consumer Healthcare Ltd(Merged)
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|
| Total Revenue Annual | 4,782.01 | 4,316.52 | 3,991.28 |
| Operating Expenses Annual | 3,641.04 | 3,433.16 | 3,152.97 |
| Operating Profit Annual | 1,573.57 | 1,140.76 | 1,077.37 |
| Interest Annual | 0.78 | 2.03 | 2.78 |
| Depreciation | 60.35 | 64.14 | 63.87 |
| Net Profit Annual | 982.80 | 700.10 | 656.68 |
| Tax Annual | 529.49 | 374.26 | 353.74 |
| Particulars | Mar 2019 |
|---|---|
| Total Revenue Annual | 4,782.01 |
| Operating Expenses Annual | 3,641.04 |
| Operating Profit Annual | 1,573.57 |
| Interest Annual | 0.78 |
| Depreciation | 60.35 |
| Net Profit Annual | 982.80 |
| Tax Annual | 529.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|
| Cash Flow at the Beginning | 614.10 | 700.91 | 1,061.67 |
| Cash Flow from Operations | 671.07 | 723.04 | 602.97 |
| Cash Flow from Investing | -335.06 | -446.45 | -602.40 |
| Cash Flow from Financing | -376.80 | -363.40 | -361.33 |
| Cash Flow at the End | 573.32 | 614.10 | 700.91 |
| Particulars | Mar 2019 |
|---|---|
| Cash Flow at the Beginning | 614.10 |
| Cash Flow from Operations | 671.07 |
| Cash Flow from Investing | -335.06 |
| Cash Flow from Financing | -376.80 |
| Cash Flow at the End | 573.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|
| PBDIT Margin (%) | 32.91 | 26.06 | 24.34 |
| PBIT Margin (%) | 31.64 | 24.59 | 22.89 |
| PBT Margin (%) | -8.93 | 12.48 | 14.66 |
| Net PROFIT Margin (%) | 20.55 | 15.99 | 14.84 |
| Return On Networth / Equity (%) | 25.93 | 21.19 | 22.18 |
| Return On Networth /Employed (%) | 38.19 | 30.59 | 31.58 |
| Return On Assets (%) | 24.87 | 19.83 | 20.48 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.21 | 1.24 | 1.38 |
| Particulars | Mar 2019 |
|---|---|
| PBDIT Margin (%) | 32.91 |
| PBIT Margin (%) | 31.64 |
| PBT Margin (%) | -8.93 |
| Net PROFIT Margin (%) | 20.55 |
| Return On Networth / Equity (%) | 25.93 |
| Return On Networth /Employed (%) | 38.19 |
| Return On Assets (%) | 24.87 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|
| Fixed Assets Annual | 467.21 | 478.07 | 495.92 |
| Total Current Assets Annual | 5,267.42 | 4,562.00 | 4,139.13 |
| Non Current Assets Annual | 800.67 | 850.66 | 815.55 |
| Total Shareholders Funds Annual | 4,094.71 | 3,485.12 | 3,122.67 |
| Total Assets Annual | 6,068.09 | 5,412.66 | 4,954.68 |
| Particulars | Mar 2019 |
|---|---|
| Fixed Assets Annual | 467.21 |
| Total Current Assets Annual | 5,267.42 |
| Non Current Assets Annual | 800.67 |
| Total Shareholders Funds Annual | 4,094.71 |
| Total Assets Annual | 6,068.09 |
No Data Availabe
